Major investment on network with focus on immunometabolism

The Novo Nordisk Foundation has awarded a total of DKK 80 million for two interdisciplinary research programmes exploring the relationship between metabolism and inflammation in metabolic diseases.

Mikael Rydén, Unit for Endocrinology and Diabetes participates in both programmes and Myriam Aouadi, ICMC, participates in one of them.

The funded programmes both combine the fields of immunology and metabolic research and bring together investigators from three institutions; University of Copenhagen, Denmark, University of Oxford, Great Britain, and the Karolinska Institute, Sweden.